BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 6060954)

  • 21. [Study on Cushing's syndrome].
    Nishimura T
    Nihon Naibunpi Gakkai Zasshi; 1965 Oct; 41(7):825-36. PubMed ID: 5895458
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of aminoglutethimide and reserpine on the human pituitary-adrenal axis: remission of a case of Cushing's disease.
    Givens JR; Camacho A; Patterson P
    Metabolism; 1970 Oct; 19(10):818-30. PubMed ID: 4918596
    [No Abstract]   [Full Text] [Related]  

  • 23. [Case of pheochromocytoma and Cushing's syndrome due to bilateral adrenocortical nodular hyperplasia which was suspected to be under the pituitary and adrenal dual control].
    Miyazaki S; Ishida M; Kubo Y; Nakagawa T; Kawamura M; Matsushima T; Hayashi H; Kataoka R; Naito C
    Nihon Naika Gakkai Zasshi; 1983 Jun; 72(6):803-12. PubMed ID: 6655336
    [No Abstract]   [Full Text] [Related]  

  • 24. Diagnostic and therapeutic problems in spontaneous Cushing's syndrome. A review with five case reports.
    Poulsen JE; Asfeldt VH
    Scand J Urol Nephrol; 1972; 6():Suppl 15:89-96. PubMed ID: 4644112
    [No Abstract]   [Full Text] [Related]  

  • 25. Adrenocortical indices during fasting in obesity.
    Sabeh G; Alley RA; Robbins TJ; Narduzzi JV; Kenny FM; Danowski TS
    J Clin Endocrinol Metab; 1969 Mar; 29(3):373-6. PubMed ID: 5773070
    [No Abstract]   [Full Text] [Related]  

  • 26. Cushing's syndrome secondary to a benign paraganglioma.
    Cardenas F; Coffey RJ; Meloni R
    Am Surg; 1970 May; 36(5):283-9. PubMed ID: 4314687
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adrenal Cushing's syndrome: clinico-pathologic review of 18 cases].
    Gómez-Huelgas R; Martín-Jiménez L; Valdivielso L; Collazos J; Renedo G; Ramos F; Arrieta F; Oliva H; Herrera Pombo JL
    Rev Clin Esp; 1984 Feb; 172(4):211-7. PubMed ID: 6739878
    [No Abstract]   [Full Text] [Related]  

  • 28. [Glucocorticoid function of the adrenal glands in patients with micro- and macrofocal myocardial infarct].
    Tsiomik VA; Gvatua NA; Goncharova DN; Gorkum MA
    Vrach Delo; 1967; 9():45-9. PubMed ID: 5621779
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
    Philbert M; Laudat MH; Laudat P; Bricaire H
    Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418
    [No Abstract]   [Full Text] [Related]  

  • 30. [Some findings on the androgen functions of the adrenal cortex in female obesity].
    Ferramosca B; Bacci G; Frizziero L; Masiello O
    Endocrinol Sci Cost; 1967 Nov; 29(5):323-43. PubMed ID: 4892898
    [No Abstract]   [Full Text] [Related]  

  • 31. Cortisol and its metabolites in the plasma and urine in Cushing's syndrome with chronic renal failure (CRF), compared to Cushing's syndrome without CRF.
    Otokida K; Fujiwara T; Oriso S; Kato M
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):651-6. PubMed ID: 2795994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of d-2(p-aminophenyl)-2-phenylethylamine (SK&F-12185) in Cushing's syndrome associated with adrenocortical carcinoma.
    Gabrilove JL; Nicolis GL; Gallagher TF
    Metabolism; 1968 Oct; 17(10):936-42. PubMed ID: 4877990
    [No Abstract]   [Full Text] [Related]  

  • 33. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia.
    Horiba N; Suda T; Aiba M; Naruse M; Nomura K; Imamura M; Demura H
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2336-41. PubMed ID: 7629226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Remission in Cushing's syndrome with o,p'-DDD.
    Southren AL; Tochimoto S; Strom L; Ratuschni A; Ross H; Gordon G
    J Clin Endocrinol Metab; 1966 Mar; 26(3):268-78. PubMed ID: 4286017
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of o,p'-DDD on cortisol secretory pattern in Cushing's syndrome.
    Hellman L; Weitzman ED; Roffwarg H; Fukushima DK; Yoshida K; Zumoff B; Gallagher TF
    J Clin Endocrinol Metab; 1970 Aug; 31(2):227-30. PubMed ID: 4316529
    [No Abstract]   [Full Text] [Related]  

  • 36. Malignant melanoma with ectopic production of adrenocorticotropic hormone. Palliative treatment with inhibitors of adrenal steroid biosynthesis.
    Carey RM; Orth DN; Hartmann WH
    J Clin Endocrinol Metab; 1973 Mar; 36(3):482-7. PubMed ID: 4119547
    [No Abstract]   [Full Text] [Related]  

  • 37. [Investigation of Cushing's syndrome. The diagnostic value of the dexamethasone suppression test, the metopirone test and the CRF test].
    Johannesen O; Jørgensen H; Frey H; Norman N
    Tidsskr Nor Laegeforen; 1989 Sep; 109(26):2678-82. PubMed ID: 2554527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Values for urinary free cortisol during treatment with amino-glutethimide for Cushing's syndrome.
    Schmitt KW; Juselius R; Hanlon J; Steed D
    Clin Chem; 1973 Sep; 19(9):1067-8. PubMed ID: 4744809
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization of adrenal autonomy in Cushing's syndrome: a comparison between in vivo and in vitro responsiveness of the adrenal gland.
    Lamberts SW; Zuiderwijk J; Uitterlinden P; Blijd JJ; Bruining HA; de Jong FH
    J Clin Endocrinol Metab; 1990 Jan; 70(1):192-9. PubMed ID: 2152930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of ACTH administration on aldosterone production in non salt-losing congenital adrenal hyperplasia.
    Beitins IZ; Bayard F; Kowarski A; Migeon CJ
    J Clin Endocrinol Metab; 1972 Oct; 35(4):595-603. PubMed ID: 4340790
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.